KYG549581067
KYG549581067
HANSOH PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 15.028.324.000 | 12.260.814.000 | 22.6% |
| Cost of Revenue | 1.497.867.000 | 1.105.408.000 | 35.5% |
| Gross Profit | 13.530.457.000 | 11.155.406.000 | 21.3% |
| 7.983.447.000 | 7.124.290.000 | 12.1% | |
| Operating Income | 5.547.010.000 | 4.031.116.000 | 37.6% |
| Pretax Income | 6.550.581.000 | 5.085.182.000 | 28.8% |
| Net Income Common Stockholders | 5.555.461.000 | 4.371.825.000 | 27.1% |
| -- | -- | -- | |
| -- | -- | -- |